西酞普兰对抑郁模型大鼠的治疗作用及机制研究

doi:10.3969/j.issn.1006-7795.2013.02.015

首都医科大学学报 ›› 2013, Vol. 34 ›› Issue (2): 239-244.doi: 10.3969/j.issn.1006-7795.2013.02.015

西酞普兰对抑郁模型大鼠的治疗作用及机制研究

姚瑶¹, 杨健², 裴昱², 王勇¹, 马辛², 王晓民¹, 汪璇¹

1. 首都医科大学基础医学院生理学系, 神经生物学系, 教育部神经变性病重点实验室, 北京 100069;
2. 首都医科大学附属北京安定医院精神科, 北京 100088

收稿日期:2012-10-18 出版日期:2013-04-21 发布日期:2013-04-17
通讯作者: 汪璇 E-mail:wangxuan@ccmu.edu.cn
基金资助:
国家重点基础研究发展计划项目(973 project)(2011CB504100)和北京市博士后科研活动经费资助(2011ZZ-10)。

Therapeutic effect of citalopram on depressive model rats and the relative mechanism

YAO Yao¹, YANG Jian², PEI Yu², WANG Yong¹, MA Xin², WANG Xiaomin¹, Wang Xuan¹

1. Departments of Physiology and Neurobiology, School of Basic Medical Science, Capital Medical University, Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Beijing 100069, China;
2. Departments of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing 100088, China

Received:2012-10-18 Online:2013-04-21 Published:2013-04-17
Supported by:
This study was supported by National Basic Research Program of China(2011CB504100), the Beijing Postdoctoral Research Foundation(2011ZZ-10).

摘要/Abstract

摘要：

目的通过连续腹腔注射西酞普兰,研究西酞普兰对慢性不可预知性应激(chronic unpredicted stress,CUS)抑郁模型大鼠的保护作用及相关机制。方法 1) 建立慢性不可预知性应激大鼠抑郁模型,采用包括束缚、强迫游泳、禁食水、夹尾等多种方法连续刺激成年雄性SD大鼠4周,检测其抑郁行为。2)模型成功后,对模型组大鼠连续腹腔注射不同剂量西酞普兰3周,观察大鼠行为学的改善。3)行为学检测后,将大鼠立即处死,采用ELISA和Western blotting的方法检测血清和海马中脑源性神经营养因子(brain-derived neurotrophic factor,BDNF)的含量。结果 1)慢性不可预知性应激4周后,模型组大鼠体质量降低,糖水偏好明显下降,旷场实验垂直和水平运动距离明显减少,提示造模成功。2)给药3周后,10 mg·kg^-1·d^-1西酞普兰能够明显提高模型组大鼠糖水偏好及旷场实验垂直和水平运动距离,提示抑郁症状得到改善。3)10 mg·kg^-1·d^-1西酞普兰组模型大鼠血清和海马BDNF含量与模型组相比显著升高。结论慢性不可预知性应激4周可使大鼠出现抑郁症状,10 mg·kg^-1·d^-1西酞普兰可以改善模型大鼠的抑郁行为,其机制可能与提高了海马BDNF的含量相关。

关键词: 西酞普兰, 抑郁, 脑源性神经营养因子, 慢性不可预知性应激

Abstract:

Objective To explore the protective effect of citalopram on depressive model rats and the relative mechanism through continuous intraperitoneal injection of citalopram. Methods Establishing chronic unpredictable stress rat model. It consisted of a variety of stressors applied randomly every day for 4 weeks, The type of stressor included restraint, forced swim, food or water deprivation, tail pinch and so on. Successful model rats were subjected to continuous intraperitoneal injection with different doses of citalopram for 3 weeks, followed by behavioral tests. Sacrificing the rats immediately after the last behavioral test, the content of brain-derived neurotrophic factor(BDNF) in the hippocampus and serum was detected by ELISA and Western Blotting. Results After chronic unpredictable stress for 4 weeks, the model rats displayed lower weight gain, decreased sucrose preference, and reduced locomotor activity. Intraperitoneal injection with 10 mg·kg^-1·d^-1 citalopram for 3 weeks could significantly increase the sucrose preference and the movement distance of model rats. Intraperitoneal injection with 10 mg·kg^-1·d^-1 citalopram for 3 weeks could significantly increased the content of BDNF in the serum and the hippocampus of model rats. Conclusion Rats subjected to chronic unpredictable stress for 4 weeks displayed apparent depressive symptoms. Intraperitoneal injection with 10 mg·kg^-1·d^-1 citalopram for 3 weeks could improve the depressive behavior of model rats, the underlying mechanism may relate to increased BDNF content in the hippocampus.

Key words: citalopram, depression, brain-derived neurotrophic factor, chronic unpredictable stress

中图分类号:

姚瑶, 杨健, 裴昱, 王勇, 马辛, 王晓民, 汪璇. 西酞普兰对抑郁模型大鼠的治疗作用及机制研究[J]. 首都医科大学学报, 2013, 34(2): 239-244.

YAO Yao, YANG Jian, PEI Yu, WANG Yong, MA Xin, WANG Xiaomin, Wang Xuan. Therapeutic effect of citalopram on depressive model rats and the relative mechanism[J]. Journal of Capital Medical University, 2013, 34(2): 239-244.

参考文献

[1] Lopez A D, Murray C C. The global burden of disease, 1990-2020[J]. Nat Med, 1998,4(11):1241-1243.

[2] Overo K F. Preliminary studies of the kinetics of citalopram in man[J]. Eur J Clin Pharmacol, 1978,9(14):69-73.

[3] Dwivedi Y. Brain-derived neurotrophic factor: role in depression and suicide[J]. Neuropsychiatr Dis Treat. 2009, 5:433-449.

[4] . A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. A second report by the joint committee of the Medical Research Council and Nuffield Foundation on clinical trials of cortisone, ACTH, and other therapeutic measures in chronic rheumatic diseases[J]. Ann Rheum Dis, 1960,19:331-337.

[5] Berton O, Nestler E J. New approaches to antidepressant drug discovery: beyond monoamines[J]. Nat Rev Neurosci, 2006,7(2):137-151.

[6] Castren E, Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity[J]. Dev Neurobiol, 2010,70(5):289-297.

[7] Katz R J. Animal models and human depressive disorders[J]. Neurosci Biobehav Rev, 1981,5(2):231-246.

[8] Willner P, Towell A, Sampson D, et al. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant[J]. Psychopharmacology(Berl), 1987,93(3):358-364.

[9] Luo K R, Hong C J, Liou Y J, et al. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2010,34(8):1433-1439.

[10] Wurtman R J. Genes, stress, and depression[J]. Metabolism, 2005,54(5 Suppl 1):16-19.

[11] 常凤友.难治性抑郁症的增效治疗[J].中国煤炭工业医学杂志,2011,14(11):1730.

[12] 付华斌,陈峰,罗克勇,等.难治性抑郁症的研究进展[J].解放军医药杂志,2011,23(3):67-79.

[13] Willner P. Animal models as simulations of depression[J]. Trends Pharmacol Sci, 1991,12(4):131-136.

[14] Davies A M. The role of neurotrophins in the developing nervous system[J]. J Neurobiol, 1994,25(11):1334-1348.

[15] Angelucci F, Brene S, Mathe A A. BDNF in schizophrenia, depression and corresponding animal models[J]. Mol Psychiatry, 2005,10(4):345-352.

[16] 尹烈虎,李学成,陆地,等.BDNF用于抑郁症辅助诊断和疗效判断的初步研究[J].西南国防医药,2012,22(2):155-158.

[17] Matrisciano F, Bonaccorso S, Ricciardi A, et al. Changes in BDNF serum levels in patients with major depression disorder(MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine[J]. J Psychiatr Res, 2009,43(3):247-254.

[18] Piccinni A, Marazziti D, Catena M, et al. Plasma and serum brain-derived neurotrophic factor(BDNF) in depressed patients during 1 year of antidepressant treatments[J]. J Affect Disord, 2008,105(1-3):279-283.

编辑推荐

Metrics

阅读次数

全文

HTML			PDF

最新录用	在线预览	正式出版	最新录用	在线预览	正式出版
0	0	0	0	0	70

来源	本网站	其他网站

次数	53	17
比例	76%	24%

摘要

最新录用	在线预览	正式出版

0	0	71

西酞普兰对抑郁模型大鼠的治疗作用及机制研究

Therapeutic effect of citalopram on depressive model rats and the relative mechanism

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘鑫子, 李自艳, 郑思思, 朱虹, 尹冬青, 贾竑晓. 基于机器学习的单相抑郁与双相抑郁鉴别的脉图参数分类模型[J]. 首都医科大学学报, 2022, 43(3): 407-414.
[2]	罗炯, 孙丛丛, 潘伟刚, 王丹, 史晓宁, 王茜, 金文青, 梁立荣, 杨春林, 马辛, 任艳萍. 经颅交流电刺激联合抗抑郁药对抑郁发作的疗效及安全性[J]. 首都医科大学学报, 2022, 43(2): 244-248.
[3]	孙丛丛, 吴涵, 周丹娜, 姜玮, 王雯, 杨春林, 马辛, 任艳萍. 脑源性神经营养因子对经颅磁刺激治疗难治性抑郁症的疗效预测作用[J]. 首都医科大学学报, 2022, 43(2): 227-232.
[4]	任艳萍, 张俊岩, 吴涵, 罗炯, 杨春林, 马辛, 姜玮. 磁惊厥治疗与无抽搐电痉挛治疗抑郁发作的早期疗效及对认知功能的影响[J]. 首都医科大学学报, 2022, 43(2): 239-243.
[5]	王荣欣, 王晶, 胡水清. 伴有食管外症状的反流性食管炎患者的危险因素分析[J]. 首都医科大学学报, 2022, 43(1): 132-137.
[6]	林雪霏, 吴楠, 张海萍. 多汗症患者焦虑抑郁状态及睡眠情况研究[J]. 首都医科大学学报, 2021, 42(5): 841-846.
[7]	刘珊珊, 陈旭, 李亚琼, 袁晓菲, 于红晔, 房萌. 新型冠状病毒肺炎疫情期间北京市青少年抑郁焦虑情况调查及影响因素[J]. 首都医科大学学报, 2021, 42(3): 412-417.
[8]	杨楠, 丁锚, 黄语悠, 房亚兰, 师文娟, 赵咏梅. 一氧化氮在大鼠短暂性局灶性脑缺血损伤中对神经生长因子和脑源性神经营养因子表达的影响[J]. 首都医科大学学报, 2020, 41(6): 908-913.
[9]	尹星琪, 于彩果, 柯静, 赵冬, 于可. 2型糖尿病患者新型冠状病毒肺炎流行期间心理状态及行为调查[J]. 首都医科大学学报, 2020, 41(6): 970-977.
[10]	王建平, 桂沛君, 谢瑛. 经颅直流电刺激治疗轻中度老年抑郁症的临床观察[J]. 首都医科大学学报, 2019, 40(6): 948-952.
[11]	李苗, 王群松, 袁国桢. 金匮肾气丸治疗肾虚肝郁型抑郁症的治疗效果及其对人血清神经生长因子的影响[J]. 首都医科大学学报, 2019, 40(2): 220-225.
[12]	蒲连美, 李瑛, 李红, 李响, 阮杨, 韩福生, 田春营, 金泽宁. 冠状动脉粥样硬化性心脏病患者及其家属在手术前后心理状态的对比研究[J]. 首都医科大学学报, 2019, 40(1): 112-118.
[13]	王培培, 莫少华, 马昕宇, 张嘉玲, 徐志卿, 王静. 结合自评量表和认知任务测量医学生抑郁情绪[J]. 首都医科大学学报, 2018, 39(6): 889-893.
[14]	时丹丹, 杨健, 张金钮, 王刚. 东莨菪碱对大鼠强迫游泳行为的影响及其作用靶点[J]. 首都医科大学学报, 2018, 39(5): 630-635.
[15]	唐利荣, 郑伟, 赵秀芹, 任艳萍, 向应强, 高越, 徐秋月, 马辛. 康复技能训练对抑郁症患者症状缓解和生活质量的作用[J]. 首都医科大学学报, 2018, 39(5): 636-640.